Please use this identifier to cite or link to this item:
Title: Anisamide-Anchored Lyotropic Nano-Liquid Crystalline Particles with AIE Effect: A Smart Optical Beacon for Tumor Imaging and Therapy
Authors: Urandur, Sandeep
Banala, Venkatesh Teja
Shukla, Ravi Prakash
Pratibha, R.
Keywords: aggregation-induced emission
liquid crystals
optical imaging
sigma receptors
Issue Date: 18-Apr-2018
Publisher: American Chemical Society
Citation: ACS Applied Materials & Interfaces, 2018, Vol. 10, p 12960–12974
Abstract: The prospective design of nanocarriers for personalized oncotherapy should be an ensemble of targeting, imaging, and noninvasive therapeutic capabilities. Herein, we report the development of the inverse hexagonal nano-liquid crystalline (NLC) particles that are able to host formononetin (FMN), a phytoestrogen with known anticancer activity, and tetraphenylethene (TPE), an iconic optical beacon with aggregation-induced emission (AIE) signature, simultaneously. Ordered three-dimensional mesoporous internal structure and high-lipid-volume fraction of NLC nanoparticles (NLC NPs) frame the outer compartment for the better settlement of payloads. Embellishment of these nanoparticles by anisamide (AA), a novel sigma receptor targeting ligand using carbodiimide coupling chemistry ensured NLC’s as an outstanding vehicle for possible utility in surveillance of tumor location as well as the FMN delivery through active AIE imaging. The size and structural integrity of nanoparticles were evaluated by quasi-elastic light scattering, cryo field emission scanning electron microscopy small-angle X-ray scattering. The existence of AIE effect in the nanoparticles was evidenced through the photophysical studies that advocate the application of NLC NPs in fluorescence-based bioimaging. Moreover, confocal microscopy illustrated the single living cell imaging ability endowed by the NLC NPs. In vitro and in vivo studies supported the enhanced efficacy of targeted nanoparticles (AA-NLC-TF) in comparison to nontargeted nanoparticles (NLC-TF) and free drug. Apparently, this critically designed multimodal NLC NPs may establish a promising platform for targeted and image-guided chemotherapy for breast cancer.
Description: Restricted Access.
Alternative Location:
Copyright: 2018 American Chemical Society
Appears in Collections:Research Papers (SCM)

Files in This Item:
File Description SizeFormat 
2018_ACS Applied Materials and Interfaces_V10_p12960-12974.pdf
  Restricted Access
Restricted Access13.19 MBAdobe PDFView/Open Request a copy

Items in RRI Digital Repository are protected by copyright, with all rights reserved, unless otherwise indicated.